萬里揚(002434.SZ)擬1.65億元轉讓金興內飾100%股權
格隆匯12月24日丨萬里揚(002434.SZ)公佈,2019年12月24日,公司與浙江東順汽車飾件有限公司(以下簡稱“東順汽車飾件”)簽署了《關於遼寧金興汽車內飾有限公司之股權轉讓協議》,公司將持有的全資子公司遼寧金興汽車內飾有限公司(以下簡稱“金興內飾”)100%股權以人民幣1.65億元的價格全部轉讓給東順汽車飾件。股權轉讓完成後,公司不再持有金興內飾的股權。
本次對外轉讓金興內飾的全部股權,剝離持續虧損的資產,有助於公司進一步清晰產業結構,推動公司集中精力專注於汽車傳動系統主業的經營發展,不斷深化資源整合,大力發展優勢業務,有效改善和提升公司的盈利能力,推動公司健康持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.